| |
| |
|
| Insider
Information: |
Fletcher R John |
| Relationship: |
Director |
| City: |
Beverly |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
443,308 |
|
|
Indirect Shares
|
617,551 |
|
|
| Direct
Value |
$1,063,041 |
|
|
|
Indirect Value
|
$1,176 |
|
|
| Total
Shares |
1,060,859 |
|
|
| Total
Value |
$1,064,217 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
2
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
5
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-5.0
|
2.0
|
| Percentage
Gain/Loss : |
 -44.6%
|
 98.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Axcelis Technologies Inc |
ACLS |
Director |
2021-02-17 |
1,354 |
2003-12-17 |
0 |
Premium* |
|
|
NMT Medical Inc |
NMTI |
Director |
2004-12-14 |
151,756 |
2004-12-14 |
83,344 |
Premium* |
|
|
Panacos Pharma Inc |
PANC |
Director |
|
0 |
2005-09-15 |
528,147 |
Premium* |
|
|
Spectranetics Corp |
SPNC |
Director |
2017-08-09 |
0 |
2005-04-29 |
0 |
Premium* |
|
|
ClearPoint Neuro, Inc |
CLPT |
Director |
2024-05-14 |
91,950 |
2018-03-30 |
0 |
Premium* |
|
|
Repro Medical Systems Inc |
REPR |
Chairman of the Board,... |
2024-03-31 |
174,353 |
2019-06-14 |
0 |
Premium* |
|
|
Vyant Bio Ord Shs |
VYNT |
Director |
2023-01-17 |
23,895 |
2023-01-17 |
6,060 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SPNC |
Spectranetics Corp |
Director |
– • – |
2017-08-09 |
4 |
D |
$38.50 |
$5,455,335 |
D/D |
(141,697) |
0 |
0 |
- |
|
| ACLS |
Axcelis Technologies Inc |
Director |
– • – |
2020-05-28 |
4 |
S |
$26.52 |
$1,345,890 |
D/D |
(50,750) |
8,235 |
0 |
% |
|
| SPNC |
Spectranetics Corp |
Director |
– • – |
2015-03-06 |
4 |
S |
$34.35 |
$764,200 |
D/D |
(22,245) |
109,954 |
0 |
- |
|
| NMTI |
NMT Medical Inc |
Director |
– • – |
2004-12-14 |
4 |
S |
$3.90 |
$593,783 |
I/I |
(152,252) |
83,344 |
|
- |
|
| ACLS |
Axcelis Technologies Inc |
Director |
– • – |
2019-12-11 |
4 |
S |
$22.96 |
$516,600 |
D/D |
(22,500) |
52,104 |
0 |
- |
|
| ACLS |
Axcelis Technologies Inc |
Director |
– • – |
2019-12-12 |
4 |
S |
$23.52 |
$470,400 |
D/D |
(20,000) |
52,104 |
0 |
- |
|
| ACLS |
Axcelis Technologies Inc |
Director |
– • – |
2019-03-13 |
4 |
S |
$20.26 |
$455,950 |
D/D |
(22,500) |
45,872 |
0 |
- |
|
| ACLS |
Axcelis Technologies Inc |
Director |
– • – |
2021-02-17 |
4 |
S |
$39.00 |
$268,359 |
D/D |
(6,881) |
1,354 |
0 |
% |
|
| SPNC |
Spectranetics Corp |
Director |
– • – |
2015-03-06 |
4 |
OE |
$5.31 |
$238,950 |
D/D |
45,000 |
132,199 |
0 |
- |
|
| PANC |
Panacos Pharma Inc |
Director |
– • – |
2005-09-15 |
4 |
S |
$9.83 |
$215,202 |
I/I |
(21,853) |
528,147 |
|
- |
|
| ACLS |
Axcelis Technologies Inc |
Director |
– • – |
2019-12-11 |
4 |
OE |
$6.40 |
$159,600 |
D/D |
22,500 |
74,604 |
0 |
- |
|
| ACLS |
Axcelis Technologies Inc |
Director |
– • – |
2019-12-12 |
4 |
OE |
$6.40 |
$136,000 |
D/D |
20,000 |
72,104 |
0 |
- |
|
| REPR |
Repro Medical Systems Inc |
Chairman of the Board |
– • – |
2021-05-17 |
4 |
B |
$4.30 |
$107,500 |
D/D |
25,000 |
82,990 |
2.39 |
% |
|
| SPNC |
Spectranetics Corp |
Director |
– • – |
2015-10-26 |
4 |
B |
$12.41 |
$99,297 |
D/D |
8,000 |
121,728 |
2.39 |
- |
|
| SPNC |
Spectranetics Corp |
Director |
– • – |
2015-10-28 |
4 |
B |
$12.04 |
$99,201 |
D/D |
8,240 |
129,968 |
2.39 |
- |
|
| REPR |
Repro Medical Systems Inc |
Chairman of the Board |
– • – |
2020-11-30 |
4 |
B |
$4.48 |
$94,313 |
D/D |
21,052 |
50,050 |
2.39 |
% |
|
| SPNC |
Spectranetics Corp |
Director |
– • – |
2008-02-25 |
4 |
B |
$8.91 |
$89,080 |
D/D |
10,000 |
20,000 |
2.39 |
- |
|
| SPNC |
Spectranetics Corp |
Director |
– • – |
2011-06-09 |
4 |
A |
$5.84 |
$60,000 |
D/D |
10,274 |
45,274 |
0 |
- |
|
| SPNC |
Spectranetics Corp |
Director |
– • – |
2012-05-31 |
4 |
A |
$9.87 |
$60,000 |
D/D |
6,079 |
78,562 |
0 |
- |
|
| SPNC |
Spectranetics Corp |
Director |
– • – |
2012-05-25 |
4 |
B |
$9.90 |
$59,556 |
D/D |
6,000 |
72,483 |
2.39 |
- |
|
| ACLS |
Axcelis Technologies Inc |
Director |
– • – |
2019-03-13 |
4 |
OE |
$1.76 |
$59,200 |
D/D |
22,500 |
55,872 |
0 |
- |
|
| VYNT |
Vyant Bio Ord Shs |
Director |
– • – |
2021-05-24 |
4 |
B |
$3.39 |
$51,835 |
I/I |
15,300 |
30,300 |
2.1 |
% |
|
| VYNT |
Vyant Bio Ord Shs |
Director |
– • – |
2021-05-21 |
4 |
B |
$3.33 |
$49,949 |
I/I |
15,000 |
15,000 |
2.1 |
% |
|
| ACLS |
Axcelis Technologies Inc |
Director |
– • – |
2007-08-24 |
4 |
B |
$4.88 |
$48,800 |
D/D |
10,000 |
48,693 |
2.39 |
- |
|
| SPNC |
Spectranetics Corp |
Director |
– • – |
2005-04-29 |
4 |
B |
$5.10 |
$45,900 |
D/D |
9,000 |
10,000 |
2.39 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
